Loja
A mostrar 1–16 de 18 resultados
-

TOFADX Tofacitinib 5mg
Tofacitinib is a JAK inhibitor that effectively inhibits the activity of JAK1 and JAK3,…Escolher opcao This product has multiple variants. The options may be chosen on the product page -

TOFADX Tofacitinib
Tofacitinib is a JAK inhibitor that effectively inhibits the activity of JAK1 and JAK3,…Escolher opcao This product has multiple variants. The options may be chosen on the product page -

BESIDX Abemaciclib
Abemaciclib is a selective CDK4 and CDK6 inhibitor used to treat advanced or metastatic…Escolher opcao This product has multiple variants. The options may be chosen on the product page -

ERDADX Erdafitinib 4mg
In March 2018, the U.S. Food and Drug Administration (FDA) granted erdatinib Breakthrou…Escolher opcao This product has multiple variants. The options may be chosen on the product page -

VEMUDX vemurafenib
Vemurafenib induces programmed apoptosis in melanoma cell lines. If B-Raf has the commo…Escolher opcao This product has multiple variants. The options may be chosen on the product page -

PEMIDX Pemigatinib 4.5mg
Pemigatinib inhibits tumor growth and spread by suppressing FGFR kinases in tumor cells…Escolher opcao This product has multiple variants. The options may be chosen on the product page -

ELTROMDX Eltrombopag 25
Eltrombopag is a thrombopoietin receptor agonist that works by inducing the differentia…Escolher opcao This product has multiple variants. The options may be chosen on the product page -

ELTROMDX Eltrombopag 50mg
Eltrombopag is a thrombopoietin receptor agonist that works by inducing the differentia…Escolher opcao This product has multiple variants. The options may be chosen on the product page -

DABRADX Dabrafenib 75mg
Dabrafenib is a BRAF inhibitor cancer drug, available as a mesylate. On May 29, 2013, t…Escolher opcao This product has multiple variants. The options may be chosen on the product page -

DUVACIDX Deucravacitinib 6mg
Deucravacitinib is a novel drug used to treat autoimmune diseases. Autoimmune diseases …Escolher opcao This product has multiple variants. The options may be chosen on the product page -

UPADX Upadacitinib 15mg
Upatinib is an oral, once-daily, selective, reversible JAK inhibitor that has played a …Escolher opcao This product has multiple variants. The options may be chosen on the product page -

Lucius Tofacitinib – Buy Online
Tofacitinib is a JAK inhibitor that reduces various chronic inflammatory responses by i…Adicionar ao carrinho -

Lucius Deutervacitinib – Buy Online
As the only approved TYK2 allosteric inhibitor in the world, deuterocelexitinib has sho…Adicionar ao carrinho -

Lucius Upadacitinib – Buy Online
Upatinib is a prescription drug that targets Janus kinase (JAK). In August 2021, it was…Adicionar ao carrinho

